Session Chairs: Richard Rogers, Umoja Biopharma and Sarah Rogstad, CDER, FDA

Session Description:

The future of our field is heavily dependent on innovative science from new and upcoming researchers. The Next Generation Investigator (NGI) session will showcase the cutting edge work of three very talented early career scientists. We look forward to learning what these next generation investigators have been working on to advance applications mass spectrometry.

Session Speakes:

Proteoform Specific Microheterogeneity Assessment of Biopharmaceuticals Using a Modified Orbitrap Tribrid Mass Spectrometer

Corentin Beaumal, NIBRT, National Institute for Bioprocessing Research

Middle-down Approach Using Proton Transfer Charge Reduction Enables Unambiguous Drug-Payload Localization in Cys-linked Antibody Drug Conjugates

Linda Lieu, University of Oklahoma

A Novel Mass Spectrometry-Based Footprinting Method for RNA Higher Order Structure

Natashia Yang, Washington University in St. Louis

Sarah Rogstad

Appearances